Bokf Na Has $6.87 Million Stock Holdings in Corteva, Inc. $CTVA

Bokf Na decreased its stake in Corteva, Inc. (NYSE:CTVA) by 16.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 101,513 shares of the company’s stock after selling 20,157 shares during the period. Bokf Na’s holdings in Corteva were worth $6,865,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in shares of Corteva by 0.5% during the second quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock worth $5,976,436,000 after buying an additional 373,680 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Corteva by 5.9% during the 3rd quarter. Franklin Resources Inc. now owns 18,731,627 shares of the company’s stock valued at $1,266,820,000 after acquiring an additional 1,051,389 shares in the last quarter. Geode Capital Management LLC grew its position in Corteva by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock worth $1,339,651,000 after acquiring an additional 251,693 shares during the last quarter. Norges Bank acquired a new position in Corteva in the 2nd quarter worth about $434,220,000. Finally, Legal & General Group Plc increased its holdings in Corteva by 14.3% in the 3rd quarter. Legal & General Group Plc now owns 5,753,982 shares of the company’s stock worth $389,142,000 after purchasing an additional 720,469 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Buying and Selling at Corteva

In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.14% of the stock is currently owned by company insiders.

Corteva Trading Up 1.4%

Shares of CTVA stock opened at $79.76 on Friday. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The stock has a market cap of $53.64 billion, a price-to-earnings ratio of 50.48, a PEG ratio of 2.69 and a beta of 0.72. The stock has a 50-day moving average of $73.88 and a 200-day moving average of $69.20.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue was down 1.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is 45.57%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Wells Fargo & Company lifted their price target on Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. CICC Research upped their price objective on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Wednesday, February 11th. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and lifted their target price for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Mizuho boosted their target price on shares of Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.